Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Conformis, Inc. stock logo
CFMS
Conformis
$2.26
$2.25
$1.05
$7.25
$17.80M1.3999,585 shs7,000 shs
Eargo, Inc. stock logo
EAR
Eargo
$70.50
$52.85
$1.47
$8.48
$1.46B1.523,347 shsN/A
Sientra, Inc. stock logo
SIEN
Sientra
$0.43
$0.16
$4.94
$2.08M2.044.15 million shs3.44 million shs
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
$0.76
$0.17
$6.77
$1.69M1.551.44 million shs8.72 million shs
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Conformis, Inc. stock logo
CFMS
Conformis
0.00%0.00%0.00%0.00%+43.95%
Eargo, Inc. stock logo
EAR
Eargo
0.00%0.00%0.00%+2,520.82%+1,240.30%
Sientra, Inc. stock logo
SIEN
Sientra
0.00%0.00%0.00%-69.47%-88.92%
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
0.00%0.00%0.00%0.00%-83.96%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/AN/AN/AN/A
Eargo, Inc. stock logo
EAR
Eargo
N/AN/AN/AN/AN/AN/AN/AN/A
Sientra, Inc. stock logo
SIEN
Sientra
N/AN/AN/AN/AN/AN/AN/AN/A
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Conformis, Inc. stock logo
CFMS
Conformis
2.00
HoldN/AN/A
Eargo, Inc. stock logo
EAR
Eargo
N/AN/AN/AN/A
Sientra, Inc. stock logo
SIEN
Sientra
2.00
HoldN/AN/A
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Conformis, Inc. stock logo
CFMS
Conformis
$57.06M0.31N/AN/A$4.07 per share0.56
Eargo, Inc. stock logo
EAR
Eargo
$41.11M35.61N/AN/A$4.87 per share14.48
Sientra, Inc. stock logo
SIEN
Sientra
$90.55M0.00N/AN/A($0.04) per share0.00
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
$81.98M0.00N/AN/A($3.81) per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Conformis, Inc. stock logo
CFMS
Conformis
-$50.47M-$5.61N/AN/AN/A-72.72%-86.46%-47.65%N/A
Eargo, Inc. stock logo
EAR
Eargo
-$157.49M-$7.52N/AN/A-263.14%-135.08%-96.37%N/A
Sientra, Inc. stock logo
SIEN
Sientra
-$73.31M-$5.57N/AN/AN/A-65.93%N/A-40.45%N/A
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
-$54.60M-$8.12N/AN/AN/A-64.63%-983.11%-74.49%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/A
Eargo, Inc. stock logo
EAR
Eargo
N/AN/AN/AN/AN/A
Sientra, Inc. stock logo
SIEN
Sientra
N/AN/AN/AN/AN/A
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Conformis, Inc. stock logo
CFMS
Conformis
0.64
5.07
3.30
Eargo, Inc. stock logo
EAR
Eargo
N/A
3.22
2.97
Sientra, Inc. stock logo
SIEN
Sientra
N/A
0.57
0.31
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
N/A
2.67
2.00

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Conformis, Inc. stock logo
CFMS
Conformis
10.31%
Eargo, Inc. stock logo
EAR
Eargo
80.53%
Sientra, Inc. stock logo
SIEN
Sientra
15.38%
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
26.31%

Insider Ownership

CompanyInsider Ownership
Conformis, Inc. stock logo
CFMS
Conformis
3.80%
Eargo, Inc. stock logo
EAR
Eargo
0.81%
Sientra, Inc. stock logo
SIEN
Sientra
1.53%
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
3.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Conformis, Inc. stock logo
CFMS
Conformis
2957.88 million7.58 millionNot Optionable
Eargo, Inc. stock logo
EAR
Eargo
24320.76 million20.59 millionNot Optionable
Sientra, Inc. stock logo
SIEN
Sientra
30411.96 million11.78 millionOptionable
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
2179.24 million8.96 millionOptionable

CFMS, SIEN, EAR, and SRGA Headlines

SourceHeadline
Surgalign Holdings Inc.Surgalign Holdings Inc.
thestreet.com - November 4 at 12:18 AM
Surgalign Holdings Inc (SRGAQ)Surgalign Holdings Inc (SRGAQ)
investing.com - August 15 at 6:57 AM
RT20.BE - SURGALIGN HLDGS NEW -,001RT20.BE - SURGALIGN HLDGS NEW -,001
finance.yahoo.com - July 10 at 8:46 AM
Why Is Surgalign Holdings (SRGA) Stock Up 10% Today?Why Is Surgalign Holdings (SRGA) Stock Up 10% Today?
investorplace.com - June 27 at 9:07 AM
Short Volatility Alert: Surgalign HoldingsShort Volatility Alert: Surgalign Holdings
benzinga.com - June 26 at 2:42 PM
Why Is Surgalign Holdings (SRGA) Stock Down 23% Today?Why Is Surgalign Holdings (SRGA) Stock Down 23% Today?
investorplace.com - June 26 at 10:03 AM
Surgalign Holdings, Inc.: Surgalign Receives NASDAQ Delisting Notice Following its Chapter 11 FilingSurgalign Holdings, Inc.: Surgalign Receives NASDAQ Delisting Notice Following its Chapter 11 Filing
finanznachrichten.de - June 23 at 3:32 PM
Surgalign receives Nasdaq delisting notice following bankruptcy filingSurgalign receives Nasdaq delisting notice following bankruptcy filing
massdevice.com - June 23 at 3:32 PM
Surgalign Receives NASDAQ Delisting Notice Following its Chapter 11 FilingSurgalign Receives NASDAQ Delisting Notice Following its Chapter 11 Filing
finance.yahoo.com - June 23 at 10:23 AM
Surgalign files Chapter 11 to sell global hardware, biologics businessSurgalign files Chapter 11 to sell global hardware, biologics business
massdevice.com - June 20 at 6:08 PM
Surgalign Files For Bankruptcy, Agrees To Sell Global Hardware & Biologics BusinessSurgalign Files For Bankruptcy, Agrees To Sell Global Hardware & Biologics Business
benzinga.com - June 20 at 1:07 PM
Surgalign Enters Into Definitive Agreement to Sell Global Hardware and Biologics Business Through a Structured Sale Process Under Chapter 11 of the U.S. Bankruptcy CodeSurgalign Enters Into Definitive Agreement to Sell Global Hardware and Biologics Business Through a Structured Sale Process Under Chapter 11 of the U.S. Bankruptcy Code
finance.yahoo.com - June 20 at 1:07 PM
Why Is Surgalign (SRGA) Stock Down 55% Today?Why Is Surgalign (SRGA) Stock Down 55% Today?
investorplace.com - June 20 at 10:06 AM
Surgalign plummets 42% on bankruptcy filingSurgalign plummets 42% on bankruptcy filing
msn.com - June 20 at 8:07 AM
Surgalign Plummets on Chapter 11 FilingSurgalign Plummets on Chapter 11 Filing
msn.com - June 20 at 8:07 AM
Medtech firm Surgalign files for Chapter 11 bankruptcyMedtech firm Surgalign files for Chapter 11 bankruptcy
dunyanews.tv - June 20 at 12:35 AM
Surgalign (SRGA) Upgraded to Buy: What Does It Mean for the Stock?Surgalign (SRGA) Upgraded to Buy: What Does It Mean for the Stock?
finance.yahoo.com - June 5 at 6:03 PM
Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Athira Pharma (ATHA) and Surgalign Holdings (SRGA)Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Athira Pharma (ATHA) and Surgalign Holdings (SRGA)
markets.businessinsider.com - May 23 at 1:18 PM
Surgalign to Participate at ISASS 2023 – 23rd Annual Conference Sponsored by the International Society for the Advancement of Spine Surgery and Medical Education ResourcesSurgalign to Participate at ISASS 2023 – 23rd Annual Conference Sponsored by the International Society for the Advancement of Spine Surgery and Medical Education Resources
finance.yahoo.com - May 23 at 1:18 PM
Surgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations - Yahoo FinanceSurgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations - Yahoo Finance
news.google.com - May 13 at 2:42 PM
Surgalign Holdings, Inc.: Surgalign Announces First Quarter 2023 Results and Provides Update on its Business OperationsSurgalign Holdings, Inc.: Surgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations
finanznachrichten.de - May 12 at 10:12 AM
Surgalign: Q1 Earnings Snapshot - Seattle PISurgalign: Q1 Earnings Snapshot - Seattle PI
news.google.com - May 12 at 5:11 AM
Recap: Surgalign Holdings Q1 Earnings - Surgalign Holdings ... - BenzingaRecap: Surgalign Holdings Q1 Earnings - Surgalign Holdings ... - Benzinga
news.google.com - May 12 at 5:11 AM
Surgalign Announces First Quarter 2023 Results and Provides ... - GlobeNewswireSurgalign Announces First Quarter 2023 Results and Provides ... - GlobeNewswire
news.google.com - May 12 at 5:11 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Conformis logo

Conformis

NASDAQ:CFMS
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Brazil, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.
Eargo logo

Eargo

NASDAQ:EAR
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.
Sientra logo

Sientra

NASDAQ:SIEN
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Surgalign logo

Surgalign

NASDAQ:SRGA
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spinal hardware implants and biomaterial products worldwide. It offers products for thoracolumbar procedures, including Streamline TL spinal fixation system, a system for degenerative and complex spine procedures; and Streamline MIS spinal fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops augmented reality and artificial intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. On June 19, 2023, Surgalign Holdings, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.